banner
Inquiry

Liposomes

Cat. No. Product Name Inquiry
X26-05-ZQ1280 PEG-modified lumbrokinase liposomes
X26-05-ZQ1281 N-Trimethyl chitosan-coated hydroxycamptothecin liposome (TMC60-HCPTL LPs)
X26-05-ZQ1282 RGD-modified coumarin 6-encapsulated PEGylated liposomes (RGD-PLS-C6)
X26-05-ZQ1283 RGD and poloxamer F127 co-modified docetaxel-loaded liposomes (DTX-F127-RGD-LP)
X26-05-ZQ1284 rhKGF2-EGFP liposomes
X26-05-ZQ1285 P167 peptide-modified doxorubicin long-circulating liposomes (DOX-P167-SSL)
X26-05-ZQ1286 RGD tripeptide liposomes
X26-05-ZQ1287 DOTAP/Chol nanoliposomes
X26-05-ZQ1288 PEGylated oleanolic acid nanoliposomes (PEG-OA NLs)
X26-05-ZQ1289 DSPE-PEG-K237 paclitaxel long-circulating targeted liposomes
X26-05-ZQ1290 α-Asarone long-circulating liposomes
X26-05-ZQ1291 PDP-PEG2000-DSPE modified vincristine liposomes
X26-05-ZQ1292 NGR-modified brucine liposomes
X26-05-ZQ1293 Mastoparan M peptide liposomes
X26-05-ZQ1294 HZ08 liposomes
X26-05-ZQ1295 L-Ascorbyl palmitate-modified small molecule peptide liposomes
X26-05-ZQ1296 Eu3+ fluorescence-labeled target-sensitive immunoliposomes
X26-05-ZQ1297 S2.2-PEG-MZF-NPs/DOX nanoliposomes
X26-05-ZQ1298 LPD nanoliposomes
X26-05-ZQ1299 NGR peptide-modified small interfering RNA-loaded sonosensitive liposomes
X26-05-ZQ1300 L-Asparaginase proliposomes
X26-05-ZQ1301 KTP-modified dihydroartemisinin and HMGB1 silencing siRNA co-loaded targeted cationic liposomes
X26-05-ZQ1302 N-Trimethyl chitosan-coated sparfloxacin nanoliposomes (SFNL)
X26-05-ZQ1303 RDP-modified curcumin long-circulating liposomes
X26-05-ZQ1304 iRGD peptide-modified curcumin and piperine co-loaded liposomes
X26-05-ZQ1305 RGD peptide-cell penetrating peptide R8 co-modified ergosterol and cisplatin co-loaded liposomes
X26-05-ZQ1306 RGD-mediated brain-targeted ferulic acid liposomes
X26-05-ZQ1307 PEG-PCL-PEG modified madecassoside thermosensitive liposomes
X26-05-ZQ1308 NGR-modified docetaxel pH-sensitive long-circulating liposomes (DTX/NGR-PLL)
X26-05-ZQ1309 PEG-modified emodin liposomes
X26-05-ZQ1310 PEG-modified sorafenib liposomes
X26-05-ZQ1311 OM PEGs oxymatrine PEGs liposomes
X26-05-ZQ1312 PEG-PCL-PEG triblock copolymer-modified madecassoside liposomes
X26-05-ZQ1313 DSPE-PEG-APRPG modified doxorubicin liposomes
X26-05-ZQ1314 MT peptide-modified cationic liposomes
X26-05-ZQ1315 Nano-MitoPBN liposome nanoparticles
X26-05-ZQ1316 DSPE-PEG2000-MT modified cationic liposomes
X26-05-ZQ1317 LA-SOD liposomes
X26-05-ZQ1318 H102 peptide liposomes
X26-05-ZQ1319 PH1 peptide liposomes

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.